Sphingosine and Its Analog, the Immunosuppressant 2-Amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, Interact with the CB1 Cannabinoid Receptor

  title={Sphingosine and Its Analog, the Immunosuppressant 2-Amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, Interact with the CB1 Cannabinoid Receptor},
  author={Steven W. Paugh and Michael P. Cassidy and Hengjun He and Sheldon Milstien and L. J. Sim-Selley and Sarah Spiegel and Dana E Selley},
  journal={Molecular Pharmacology},
  pages={41 - 50}
Sphingosine-1-phosphate (S1P) and cannabinoid receptors are G-protein-coupled receptors that mediate the effects of S1P and endocannabinoids, respectively. Cannabinoid receptors also mediate the effects of Δ9-tetrahydrocannabinol, the primary psychoactive ingredient in marijuana, whereas S1P receptors contribute to the immunosuppressant effects of 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol (FTY720). FTY720 is a sphingosine analog that can prevent renal graft rejections and suppress a… 

Figures and Tables from this paper

Sphingosine‐1‐phosphate receptors mediate neuromodulatory functions in the CNS

It is reported that S1P stimulated G‐protein activity in the CNS, and results from [35S]GTPγS autoradiography show that in several regions a majority of this activity is mediated by S 1P1 receptors, indicating that CNS S1 P receptors are part of a physiologically relevant and widespread neuromodulatory system.

FTY720 Inhibits Ceramide Synthases and Up-regulates Dihydrosphingosine 1-Phosphate Formation in Human Lung Endothelial Cells*

The data demonstrate for the first time the ability of FTY720 to inhibit ceramide synthases and modulate the intracellular balance of signaling sphingolipids.

Advances in Neurobiology and Pharmacology of GPR12

This review analyzes all the direct available information in PubMed database about expression, function, and pharmacology of this receptor in central nervous system (CNS) trying to provide a broad overview of its current and prospective neurophysiology.

The TRPV1 Receptor Is Up-Regulated by Sphingosine 1-Phosphate and Is Implicated in the Anandamide-Dependent Regulation of Mitochondrial Activity in C2C12 Myoblasts

A dose-dependent effect of mAEA on ΔΨm, mediated by TRPV1, was evidenced; in particular, low doses were responsible for increased ΔΩm, whereas a high dose negatively modulated Δάm and cell survival.

Sphingosine-1-phosphate receptors as emerging targets for treatment of pain.

Requirement for sphingosine kinase 1 in mediating phase 1 of the hypotensive response to anandamide in the anaesthetised mouse

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

This review summarizes current data indicating the extent to which cannabinoid receptor ligands undergo orthosteric or allosteric interactions with non- CB1, non-CB2 established GPCRs, deorphanized receptors such as GPR55, ligand-gated ion channels, transient receptor potential (TRP) channels, and other ion channels or peroxisome proliferator-activated nuclear receptors.



The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt.

It is shown here that Delta(9)-tetrahydrocannabinol (THC), the major active component of marijuana, induces the activation of protein kinase B/Akt (PKB), and data indicate that activation of PKB may be responsible for some of the effects of cannabinoids in cells expressing the CB(1) receptor.

Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor.

Lysophospholipid Receptors in the Nervous System

Neuroscientists have recently begun to explore the role of lysophospholipid receptors in a number of cell types; this research has implicated these receptors in the survival, migration, and differentiation of cells in the mammalian nervous system.

Lipid Rafts Control Signaling of Type-1 Cannabinoid Receptors in Neuronal Cells

Treatment of rat C6 glioma cells with the raft disruptor methyl-β-cyclodextrin doubles the binding efficiency of type-1 cannabinoid receptors (CB1R), and CB1R activation underlies the protective effect of MCD against apoptosis.

Ceramide: a new second messenger of cannabinoid action.

Stimulation of intracellular sphingosine-1-phosphate production by G-protein-coupled sphingosine-1-phosphate receptors.

Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.

It is shown here that cannabinoid treatment induces both phosphorylation and activation of mitogen-activated protein (MAP) kinases, and that these effects are inhibited by SR 141716A, a selective CB1 antagonist.

Internalization and Recycling of the CB1 Cannabinoid Receptor

It is found that CB1 receptors are rapidly internalized following agonist binding and receptor activation, and this results show thatCB1 receptor trafficking is dynamically regulated by cannabimimetic drugs.

International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

It is considered premature to rename cannabinoid receptors after an endogenous agonist as is recommended by the International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification, because pharmacological evidence for the existence of additional types of cannabinoid receptor is emerging and other kinds of supporting evidence are still lacking.

Mice Deficient in Sphingosine Kinase 1 Are Rendered Lymphopenic by FTY720*

The results with these Sphk1 null mice reveal that some key physiologic processes that require S1P receptor signaling, such as vascular development and proper lymphocyte distribution, can occur in the absence of SPHK1.